Moderna CEO Stéphane Bancel statements on Wednesday, carried in the Financial Times overnight ICYMI.
- will not seek emergency authorization for Food and Drug Administration approval for its vaccine to use in frontline medical workers and at-risk individuals until Nov. 25 at the earliest.
- company would not seek FDA approval for use in the general population until late January
- If the vaccine is proven safe and effective, approval is unlikely to come until at least late March or early April
Link to FT, may be gated.